Public Charity

REGENERATIVE RESEARCH FOUNDATION

Based in ALBANY, NY, REGENERATIVE RESEARCH FOUNDATION operates as a Public Charity. The organization reported $7.0M in revenue, $6.5M in expenses, $9.0M in total assets for fiscal year 2024. Imperigo tracks 17 reported grant relationships connected to this organization totaling approximately $1.4M.

EIN: 203654626 ALBANY, NY Latest filing: 2024
Total Revenue$7.0M
Total Expenses$6.5M
Total Assets$9.0M
Grant Records17
Funding Total$1.4M
Filing Years2020–2024

Mission

THE PRINCIPAL MISSION OF THE REGENERATIVE RESEARCH FOUNDATION IS TO DEVELOP REGENERATIVE STEM CELL THERAPIES FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS): THE BRAIN, SPINAL CORD, AND RETINA.

Sample Grants Received

2025
SCIENTIFIC RESEARCH
$49,273
2024
FUNDING RESEARCH - CURE PILLAR OF OUR MISSION
$150,000
2024
TO SUPPORT THE WORK OF DR. SALLY TEMPLE AND DR. DAVID BUTLER - THE PRIME OF LIFE BRAIN INITIATIVE AND THE INTRA-BODY PROJECT
$65,000
2023
IN SUPPORT OF THE WORK OF DRS. SALLY TEMPLE AND DAVID BUTLER - THE PRIME OF LIFE BRAIN INITIATIVE AND THE INTRA-BODY PROJECT
$257,000
2023
IN SUPPORT OF THE WORK OF DRS. SALLY TEMPLE AND DAVID BUTLER - THE PRIME OF LIFE BRAIN INITIATIVE AND THE INTRA-BODY PROJECT
$257,000

Showing up to 5 of 17 total records — full history available with membership.

Officers & Directors

DIRECTOR Amy G Klann Phd Jd
PRINCIPAL INVESTIGATOR Caitlin Hill
PRINCIPAL INVESTIGATOR David Butler Phd
DIRECTOR David O Carpenter Md
DIRECTOR Dawn Abbuhl
CLINICAL TRIAL MANAGER Glenna Ford

Officer compensation and complete director data available with membership.

Top Grant Purposes

IN SUPPORT OF THE WORK OF DRS. SALLY TEMPLE AND DAVID BUTLER - THE PRIME OF LIFE BRAIN INITIATIVE AND THE INTRA-BODY PROJECT
$514,000 2 grants
RESEARCH
$153,024 4 grants
FUNDING RESEARCH - CURE PILLAR OF OUR MISSION
$150,000 1 grant
TO SUPPORT THE PRIME OF LIFE BRAIN INITIATIVE, IN HONOR OF DR. SALLY TEMPLE AND DR. DAVID BUTLER
$106,900 1 grant
TO FUND TAU CONSORTIUM'S ORGANOID PROJECT - "IDENTIFYING AND COMBATING EARLY CELLULAR AND MOLECULAR PHENOTYPES IN TAUOPATHIES."
$100,000 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $7.0M $6.5M $9.0M
2023 $8.8M $7.3M $7.0M
2022 $7.5M $5.8M $6.0M
2021 $5.1M $4.6M $4.5M
2020 $3.6M $3.7M $2.6M

Between 2020 and 2024, reported annual revenue grew from $3.6M to $7.0M (+96%), with total assets most recently reported at $9.0M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for REGENERATIVE RESEARCH FOUNDATION

Complete financials, all 17 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time